Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial

George Maynard, R. Kannan, Jian Liu, Weiwei Wang, Tu Kiet T. Lam, Xingxing Wang, Crista L. Adamson, Craig Hackett, Jan M. Schwab, Charles Y. Liu, Donald Leslie, David C. Chen, Ralph J. Marino, Ross Zafonte, Adam E. Flanders, Gilbert Block, Erika Smith, Stephen M. Strittmatter